| Aaron D Dresnin, DO | |
|
441 N Lakeview Ave, Anaheim, CA 92807-3028 | |
| (888) 988-2800 | |
| Not Available |
| Full Name | Aaron D Dresnin |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 441 N Lakeview Ave, Anaheim, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316095359 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 20A8943 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Aaron D Dresnin, DO 441 N Lakeview Ave, Anaheim, CA 92807-3028 Ph: (888) 988-2800 | Aaron D Dresnin, DO 441 N Lakeview Ave, Anaheim, CA 92807-3028 Ph: (888) 988-2800 |
News Archive
40 percent of people in the EU suffer from non-alcoholic steatohepatitis (fatty liver disease), a disease which is becoming increasingly more frequent as a result of diabetes and excess weight in an affluent society. Currently, it is not possible to forecast the further course of the disease - right up to cirrhosis and cancer of the liver. Furthermore, an increased risk of heart attack and kidney damage exists. In future, this should become possible using a Risk Score with different biomarkers.
Although there is little evidence that opioids effectively reduce pain from rheumatic diseases, a new study finds nearly one in three patients with lupus uses prescription opioids, often lasting longer than a year.
An international study, published today in the prestigious journal Nature Biotechnology, reveals more about human pluripotent stem cells and their genetic stability and has important implications for the development of therapies using these cells.
EpiCept Corporation announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Ceplene® (histamine dihydrochloride). EpiCept is seeking approval for Ceplene, administered concomitantly with low-dose interleukin-2 (IL-2), for the remission maintenance and prevention of relapse in patients with Acute Myeloid Leukemia (AML) in first complete remission.
What if social behavior affected the progression of even noncontagious diseases? This is precisely what has been demonstrated by French CNRS teams, with support from the French National Research Institute for Sustainable Development, Paris-Sud University, the University of Montpellier, the French Alternative Energies and Atomic Energy Commission, and colleagues from Spain and Australia.
› Verified 7 days ago
Dino A. Imperial, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Lance C. Brunner, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Marites Mcmurtrey, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Steven Chao, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 408 S Beach Blvd, Suite 106, Anaheim, CA 92804 Phone: 714-995-5471 Fax: 714-995-5815 | |
Edmond K Chu, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3055 W Orange Ave Ste 202, Anaheim, CA 92804 Phone: 714-952-0203 Fax: 714-952-1387 | |
Warren U. Wong, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Jeff D. Tracy, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 |